Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
  • AI
  • Tech
  • Cybersecurity
  • Finance
  • DeFi & Blockchain
  • Startups
  • Gaming
Dataconomy
  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
Subscribe
No Result
View All Result
Dataconomy
No Result
View All Result

Google & Stanford Say Big Data & Deep Learning Are the Future of Drug Discovery

byDataconomy News Desk
March 6, 2015
in Artificial Intelligence, News

Pande Lab at Stanford University in collaboration with Google released a paper earlier this week that focuses on how neural networks and deep learning technology could be crucial in improving the accuracy of determining which chemical compounds would be effective drug treatments for a variety of diseases.

A Google Research blog post explains how in the recent past, computational methods using deep learning with neural networks have attempted to ‘replace or augment the high-throughput screening process.’

So far, virtual drug screening has used existing data on studied diseases; but the volume of experimental drug screening data across many diseases continues to grow.

The paper titled “Massively Multitask Networks for Drug Discovery,” among other things, quantifies how the amount and diversity of screening data from a variety of diseases with very different biological processes can be used to improve the virtual drug screening predictions, explains the blog.

Working with a total of 37.8M data points across 259 distinct biological processes, using large-scale neural network training system to train at a scale 18x larger than previously used, the researchers managed to “probe the sensitivity of these models to a variety of changes in model structure and input data.”

“In the paper, we examine not just the performance of the model but why it performs well and what we can expect for similar models in the future. The data in the paper represents more than 50M total CPU hours.”

The entire effort, although it does not outline any milestone, is a step towards discerning an accurate and time saving method in drug discovery, that was traditionally almost impossible.

Follow @DataconomyMedia

(Image credit: Erich Ferdinand, via Flickr)

 

Stay Ahead of the Curve!

Don't miss out on the latest insights, trends, and analysis in the world of data, technology, and startups. Subscribe to our newsletter and get exclusive content delivered straight to your inbox.

Tags: Deep learningDrug DiscoveryGoogleHealthMachine Learning NewsletterResearch PapersstanfordWeekly Newsletter

Related Posts

Could CTEM have prevented the Oracle Cloud breach?

Could CTEM have prevented the Oracle Cloud breach?

October 5, 2025
ChatGPT reportedly reduces reliance on Reddit as a data source

ChatGPT reportedly reduces reliance on Reddit as a data source

October 3, 2025
Perplexity makes Comet AI browser free, launches background assistant and Chess.com partnership

Perplexity makes Comet AI browser free, launches background assistant and Chess.com partnership

October 3, 2025
Light-powered chip makes AI computation 100 times more efficient

Light-powered chip makes AI computation 100 times more efficient

October 3, 2025
Free and effective anti-robocall tools are now available

Free and effective anti-robocall tools are now available

October 3, 2025
Choosing the right Web3 server: OVHcloud options for startups to enterprises

Choosing the right Web3 server: OVHcloud options for startups to enterprises

October 3, 2025
Please login to join discussion

LATEST NEWS

Could CTEM have prevented the Oracle Cloud breach?

ChatGPT reportedly reduces reliance on Reddit as a data source

Perplexity makes Comet AI browser free, launches background assistant and Chess.com partnership

Light-powered chip makes AI computation 100 times more efficient

Free and effective anti-robocall tools are now available

Choosing the right Web3 server: OVHcloud options for startups to enterprises

Dataconomy

COPYRIGHT © DATACONOMY MEDIA GMBH, ALL RIGHTS RESERVED.

  • About
  • Imprint
  • Contact
  • Legal & Privacy

Follow Us

  • News
    • Artificial Intelligence
    • Cybersecurity
    • DeFi & Blockchain
    • Finance
    • Gaming
    • Startups
    • Tech
  • Industry
  • Research
  • Resources
    • Articles
    • Guides
    • Case Studies
    • Glossary
    • Whitepapers
  • Newsletter
  • + More
    • Conversations
    • Events
    • About
      • About
      • Contact
      • Imprint
      • Legal & Privacy
      • Partner With Us
No Result
View All Result
Subscribe

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Policy.